Adaptive Biotechnologies Corp. (ADPT)
23.92
-0.10
(-0.42%)
USD |
NASDAQ |
Oct 19, 16:00
23.92
0.00 (0.00%)
After-Hours: 16:50
Adaptive Biotechnologies Cash from Operations (Annual) : -45.99M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -45.99M |
| December 31, 2024 | -95.21M |
| December 31, 2023 | -156.32M |
| December 31, 2022 | -183.94M |
| December 31, 2021 | -192.73M |
| Date | Value |
|---|---|
| December 31, 2020 | -149.68M |
| December 31, 2019 | 205.40M |
| December 31, 2018 | -32.26M |
| December 31, 2017 | -34.86M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Champions Oncology, Inc. | -4.472M |
| Medpace Holdings, Inc. | 713.22M |
| Avantor, Inc. | 623.80M |
| Personalis, Inc. | -74.95M |
| 10X Genomics, Inc. | 136.05M |